Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Liabilities and Shareholders Equity (2020 - 2025)

Historic Liabilities and Shareholders Equity for NeuroPace (NPCE) over the last 6 years, with Q3 2025 value amounting to $107.3 million.

  • NeuroPace's Liabilities and Shareholders Equity rose 1137.24% to $107.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $418.2 million, marking a year-over-year increase of 529.34%. This contributed to the annual value of $94.6 million for FY2024, which is 1207.98% down from last year.
  • NeuroPace's Liabilities and Shareholders Equity amounted to $107.3 million in Q3 2025, which was up 1137.24% from $106.1 million recorded in Q2 2025.
  • In the past 5 years, NeuroPace's Liabilities and Shareholders Equity ranged from a high of $147.0 million in Q2 2021 and a low of $50.3 million during Q1 2021
  • Its 5-year average for Liabilities and Shareholders Equity is $109.3 million, with a median of $107.3 million in 2025.
  • Data for NeuroPace's Liabilities and Shareholders Equity shows a peak YoY increase of 15630.32% (in 2022) and a maximum YoY decrease of 1934.08% (in 2022) over the last 5 years.
  • Over the past 5 years, NeuroPace's Liabilities and Shareholders Equity (Quarter) stood at $133.6 million in 2021, then decreased by 14.57% to $114.1 million in 2022, then dropped by 5.66% to $107.7 million in 2023, then fell by 12.08% to $94.6 million in 2024, then grew by 13.32% to $107.3 million in 2025.
  • Its Liabilities and Shareholders Equity was $107.3 million in Q3 2025, compared to $106.1 million in Q2 2025 and $110.2 million in Q1 2025.